Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Representational Photo The exploration of novel peptides for their potential impact on metabolic pathways has been a ...

Due to increased demand, price hikes and long-term shortages, obtaining prescriptions for weight loss drugs such as ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

Novo Nordisk NVO shares have lost 5% in the past three months, which translates to approximately $29 billion in market value, ...

Novo Nordisk receives a positive opinion from the CHMP for a label update of Wegovy to reflect reduced heart failure symptoms ...

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...

What is Ozempic? An injectable drug that can be prescribed by your GP to manage Type 2 diabetes. It has also been labelled a ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...